Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer
Objectives: Stage III non-small cell lung cancer (NSCLC) has a poor prognosis. Reports suggest that five-year survival after current treatment is between 14 to 24 percent. The purpose of this retrospective study was to investigate the morbidity and mortality of patients diagnosed with stage III NSCL...
Main Authors: | Sibu P. Saha, Rohan J. Kalathiya, Daniel L. Davenport, Victor A. Ferraris, Timothy W. Mullett, Joseph B. Zwischenberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Oman Medical Specialty Board
2014-01-01
|
Series: | Oman Medical Journal |
Subjects: | |
Online Access: | http://www.omjournal.org/fultext_PDF.aspx?DetailsID=488&type=fultext |
Similar Items
-
The Evaluation of Pneumonectomy and Bronchoplasty Lobectomy in the Treatment of Non-small Cell Lung Cancer: A Report of 64 Cases
by: Heli YANG, et al.
Published: (2012-04-01) -
Post-pneumonectomy and post-lobectomy syndromes: case series and review of the literature
by: Grigoris Stratakos, et al.
Published: (2017-05-01) -
Extended Robotic Pulmonary Resections
by: Joshua A. Scheinerman, et al.
Published: (2021-02-01) -
CT Follow-Up of Postoperative Bronchopleural Fistula: Risk Factors for Progression to Chronic Complicated Infection
by: Ji-Yeon Han, et al.
Published: (2021-01-01) -
Surgical management of bronchiectasis
by: Shanker Bhandari, et al.
Published: (2016-07-01)